Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$650M |
| 2 |
Advanced Micro Devices
AMD
|
+$503M |
| 3 |
Meta Platforms (Facebook)
META
|
+$386M |
| 4 |
Accenture
ACN
|
+$343M |
| 5 |
Cognizant
CTSH
|
+$342M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$895M |
| 2 |
Adobe
ADBE
|
+$597M |
| 3 |
Microsoft
MSFT
|
+$459M |
| 4 |
Apple
AAPL
|
+$449M |
| 5 |
Nike
NKE
|
+$444M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.25% |
| 2 | Healthcare | 14.09% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Financials | 9.74% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ME
1801
DELISTED
23andMe Holding Co
ME
| $42.5K | ﹤0.01% |
1,258
| – | – |
|
1802
Tilray
TLRY
$479M
| $42.4K | ﹤0.01% |
2,509
| – | – |
|
1803
Herbalife
HLF
$1.23B
| $42.4K | ﹤0.01% |
3,036
| – | – |
|
|
TBRG
1804
DELISTED
TruBridge
TBRG
| $41.6K | ﹤0.01% |
1,648
-288
| -15% | -$7.5K |
|
1805
RE/MAX Holdings
RMAX
$200M
| $41.5K | ﹤0.01% |
2,160
-642
| -23% | -$12K |
|
1806
Phibro Animal Health
PAHC
$1.38B
| $40K | ﹤0.01% |
2,904
+136
| +5% | +$1.95K |
|
|
CNSL
1807
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $39.9K | ﹤0.01% |
10,296
+245
| +2% | +$883 |
|
1808
Domo
DOMO
$166M
| $39.2K | ﹤0.01% |
2,600
| – | – |
|
1809
Kymera Therapeutics
KYMR
$9.1B
| $38.7K | ﹤0.01% |
1,642
| – | – |
|
1810
Valley National Bancorp
VLY
$7.93B
| $38.7K | ﹤0.01% |
+4,995
| New | +$39.7K |
|
1811
Under Armour Class C
UA
$2.92B
| $37.6K | ﹤0.01% |
+5,533
| New | +$40.6K |
|
1812
Saic
SAIC
$5.03B
| $37.4K | ﹤0.01% |
333
-669
| -67% | -$69.5K |
|
1813
Shutterstock
SSTK
$205M
| $36.7K | ﹤0.01% |
753
+148
| +24% | +$8.44K |
|
1814
TD Synnex
SNX
$19.4B
| $35.4K | ﹤0.01% |
377
-12,407
| -97% | -$1.14M |
|
|
OLO
1815
DELISTED
Olo Inc
OLO
| $35.1K | ﹤0.01% |
5,414
| – | – |
|
1816
Fate Therapeutics
FATE
$281M
| $34.5K | ﹤0.01% |
7,154
| – | – |
|
1817
Coherus Oncology
CHRS
$217M
| $34.3K | ﹤0.01% |
7,765
-1,020
| -12% | -$6.02K |
|
1818
Hims & Hers Health
HIMS
$6.5B
| $34K | ﹤0.01% |
3,732
| – | – |
|
1819
Nu Holdings
NU
$68.1B
| $33.3K | ﹤0.01% |
4,184
+1,252
| +43% | +$7.69K |
|
|
VSXY
1820
Victoria's Secret
VSXY
$6.64B
| $33.2K | ﹤0.01% |
1,851
-747
| -29% | -$18.8K |
|
1821
Verra Mobility
VRRM
$615M
| $33K | ﹤0.01% |
1,675
-7,913
| -83% | -$140K |
|
1822
Crinetics Pharmaceuticals
CRNX
$8.86B
| $32.8K | ﹤0.01% |
1,820
-1,475
| -45% | -$29.4K |
|
1823
Argan
AGX
$7.98B
| $32.4K | ﹤0.01% |
+822
| New | +$33.3K |
|
1824
Kforce
KFRC
$983M
| $31.3K | ﹤0.01% |
499
| – | – |
|
1825
Golar LNG
GLNG
$4.95B
| $31K | ﹤0.01% |
1,546
| – | – |
|
Similar funds
Amundi's Q2 2023 Portfolio in Review
As of Q2 2023, Amundi held 2,165 positions worth $198B, up 6.6% from $186B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Amundi's Q2 2023 filing shows 120 new, 691 increased, 902 reduced and 140 closed positions. Its largest new stake was Clean Harbors: 361,151 shares worth $58.9M. The largest sale was UnitedHealth, an estimated $895M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Amundi's largest Q2 2023 buy was Clean Harbors: 361,151 shares worth $58.9M.
- Amundi added most to Wells Fargo 7.5% Non Cumv Perp Conv in Q2 2023, an estimated $650M increase.
- Amundi's biggest Q2 2023 reduction was UnitedHealth, cutting an estimated $895M.
- Amundi fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $111M.
- Amundi's ten largest holdings make up 22% of its $198B portfolio in Q2 2023.
- Amundi opened 120 new positions and closed 140 in Q2 2023.
- Amundi's portfolio value rose 6.6% quarter-over-quarter to $198B.
Based on Amundi's 13F filing for Q2 2023, filed 14 Aug 2023.